Literature DB >> 15652422

Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS).

Rongzhen Zhang1, Ron Gascon, Robert G Miller, Deborah F Gelinas, Jason Mass, Ken Hadlock, Xia Jin, Jeremy Reis, Amy Narvaez, Michael S McGrath.   

Abstract

Sporadic amyotrophic lateral sclerosis (sALS) is a progressive neuroinflammatory disease of spinal cord motor neurons of unclear etiology. Blood from 38 patients with sALS, 28 aged-match controls, and 25 Alzheimer's disease (AD) patients were evaluated and activated monocyte/macrophages were observed in all patients with sALS and AD; the degree of activation was directly related to the rate of sALS disease progression. Other parameters of T-cell activation and immune globulin levels showed similar disease associated changes. These data are consistent with a disease model previously suggested for AD, wherein systemic immunologic activation plays an active role in sALS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15652422     DOI: 10.1016/j.jneuroim.2004.10.009

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  57 in total

Review 1.  Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Authors:  Ximena Paez-Colasante; Claudia Figueroa-Romero; Stacey A Sakowski; Stephen A Goutman; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

2.  ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity.

Authors:  David R Beers; Weihua Zhao; Jinghong Wang; Xiujun Zhang; Shixiang Wen; Dan Neal; Jason R Thonhoff; Abdullah S Alsuliman; Elizabeth J Shpall; Katy Rezvani; Stanley H Appel
Journal:  JCI Insight       Date:  2017-03-09

Review 3.  Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

Authors:  Emanuele D'Amico; Pam Factor-Litvak; Regina M Santella; Hiroshi Mitsumoto
Journal:  Free Radic Biol Med       Date:  2013-06-21       Impact factor: 7.376

4.  Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.

Authors:  Rebecca K Sheean; Fiona C McKay; Erika Cretney; Christopher R Bye; Nirma D Perera; Doris Tomas; Richard A Weston; Karlene J Scheller; Elvan Djouma; Parvathi Menon; Stephen D Schibeci; Najwa Marmash; Justin J Yerbury; Stephen L Nutt; David R Booth; Graeme J Stewart; Mathew C Kiernan; Steve Vucic; Bradley J Turner
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

Review 5.  CSF markers in amyotrophic lateral sclerosis.

Authors:  Joanna Tarasiuk; Alina Kułakowska; Wiesław Drozdowski; Johannes Kornhuber; Piotr Lewczuk
Journal:  J Neural Transm (Vienna)       Date:  2012-05-04       Impact factor: 3.575

6.  Systemic immune system alterations in early stages of Alzheimer's disease.

Authors:  Rongzhen Zhang; Robert G Miller; Catherine Madison; Xia Jin; Ronald Honrada; Will Harris; Jonathan Katz; Dallas A Forshew; Michael S McGrath
Journal:  J Neuroimmunol       Date:  2013-02-04       Impact factor: 3.478

Review 7.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

8.  Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status.

Authors:  Christian Lunetta; Andrea Lizio; Lucio Tremolizzo; Massimiliano Ruscica; Chiara Macchi; Nilo Riva; Patrick Weydt; Ettore Corradi; Paolo Magni; Valeria Sansone
Journal:  J Neurol       Date:  2018-10-22       Impact factor: 4.849

Review 9.  Inflammatory mediators as biomarkers in brain disorders.

Authors:  Domenico Nuzzo; Pasquale Picone; Luca Caruana; Sonya Vasto; Annalisa Barera; Calogero Caruso; Marta Di Carlo
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

10.  Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Rosa Luisa Potenza; Roberta De Simone; Monica Armida; Valentina Mazziotti; Antonella Pèzzola; Patrizia Popoli; Luisa Minghetti
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.